Eugenie S. Kleinerman

α4 integrin increases anoikis of human osteosarcoma cells

E. Kleinerman, B. McIntyre, C. Diaz-Montero, 2003 .

Efficacy of Liposomal Muramyl Tripeptide (CGP 19835A) in the Treatment of Relapsed Osteosarcoma

E. Kleinerman, N. Jaffe, D. Johnston, 1995, American journal of clinical oncology.

Combination Therapy with Ifosfamide and Liposome‐Encapsulated Muramyl Tripeptide: Tolerability, Toxicity, and Immune Stimulation

E. Kleinerman, S. Jia, P. Meyers, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Altered monocyte chemotactic and activating factor gene expression in human glioblastoma cell lines increased their susceptibility to cytotoxicity

E. Kleinerman, S. Jia, T. Asano, 1996, Journal of leukocyte biology.

Intracellular Activation of Human and Rodent Macrophages by Human Lymphokines Encapsulated in Liposomes

I. Fidler, W. Fogler, E. Kleinerman, 1985, Journal of leukocyte biology.

Expression of granulocyte‐colony‐stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens

E. Kleinerman, Zhichao Zhou, P. Meyers, 2007, Cancer.

Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis

E. Kleinerman, S. Kiany, Gangxiong Huang, 2017, Oncoimmunology.

Intranasal interleukin‐12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases

E. Kleinerman, S. Jia, N. Koshkina, 2006, Cancer.

Association of αvβ3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells

E. Kleinerman, R. Langley, S. Jia, 2005, Clinical & Experimental Metastasis.